pyridoxal phosphate has been researched along with Carcinoma, Renal Cell in 3 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most common subtype is "clear cell" renal cell carcinoma (ccRCC), which features consistent metabolic abnormalities, such as highly elevated glycogen and lipid deposition." | 1.48 | Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity. ( Ackerman, D; Alwine, JC; Blair, IA; Daisak, JI; Hess, M; Keith, B; Khare, S; Lee, P; Li, B; Lin, N; Maguire, TG; Nathanson, KL; Nissim, I; Ochocki, JD; Qiu, B; Simon, MC; Worth, AJ; Wubbenhorst, B; Xie, H, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Clasen, JL | 1 |
| Heath, AK | 1 |
| Van Puyvelde, H | 1 |
| Huybrechts, I | 1 |
| Park, JY | 1 |
| Ferrari, P | 1 |
| Scelo, G | 1 |
| Ulvik, A | 1 |
| Midttun, Ø | 1 |
| Ueland, PM | 1 |
| Overvad, K | 1 |
| Eriksen, AK | 1 |
| Tjønneland, A | 1 |
| Kaaks, R | 1 |
| Katzke, V | 1 |
| Schulze, MB | 1 |
| Palli, D | 1 |
| Agnoli, C | 1 |
| Chiodini, P | 1 |
| Tumino, R | 1 |
| Sacerdote, C | 1 |
| Zamora-Ros, R | 1 |
| Rodriguez-Barranco, M | 1 |
| Santiuste, C | 1 |
| Ardanaz, E | 1 |
| Amiano, P | 1 |
| Schmidt, JA | 1 |
| Weiderpass, E | 1 |
| Gunter, M | 1 |
| Riboli, E | 1 |
| Cross, AJ | 1 |
| Johansson, M | 1 |
| Muller, DC | 1 |
| Ochocki, JD | 1 |
| Khare, S | 1 |
| Hess, M | 1 |
| Ackerman, D | 1 |
| Qiu, B | 1 |
| Daisak, JI | 1 |
| Worth, AJ | 1 |
| Lin, N | 1 |
| Lee, P | 1 |
| Xie, H | 1 |
| Li, B | 1 |
| Wubbenhorst, B | 1 |
| Maguire, TG | 1 |
| Nathanson, KL | 1 |
| Alwine, JC | 1 |
| Blair, IA | 1 |
| Nissim, I | 1 |
| Keith, B | 1 |
| Simon, MC | 1 |
| Carney, EF | 1 |
3 other studies available for pyridoxal phosphate and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
Topics: Bayes Theorem; Biomarkers; Carcinoma, Renal Cell; Case-Control Studies; Cysteine; Homocysteine; Huma | 2022 |
Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.
Topics: Animals; Arginase; Argininosuccinate Synthase; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Express | 2018 |
Altered ammonia metabolism in ccRCC.
Topics: Ammonia; Arginase; Carcinoma, Renal Cell; Humans; Polyamines; Pyridoxal Phosphate | 2018 |